Conservative group to spend $4M attacking Pelosi's drug pricing plan

Conservative group to spend $4M attacking Pelosi's drug pricing plan
© Getty Images

A conservative group plans to spend $4 million on an advertising campaign targeting Speaker Nancy PelosiNancy PelosiOvernight Defense: GAO finds administration broke law by withholding Ukraine aid | Senate opens Trump trial | Pentagon to resume training Saudi students soon Hillicon Valley: FBI to now notify state officials of cyber breaches | Pelosi rips 'shameful' Facebook | 5G group beefs up lobby team | Spotify unveils playlists for pets Hill.TV's Saagar Enjeti on impeachment: 'CNN can see through this nonsense' MORE's (D-Calif.) drug pricing plan. 

The American Action Network — a group aligned with House GOP leadership — will air the ads in 28 House districts, including some where Republicans are running competitive races in 2020, including GOP Reps. David SchweikertDavid SchweikertOvernight Health Care: New drug price hikes set stage for 2020 fight | Conservative group to spend M attacking Pelosi drug plan | Study finds Medicaid expansion improved health in Southern states Conservative group to spend M attacking Pelosi's drug pricing plan Group of veterans call on lawmakers to support impeachment, 'put country over politics' MORE (Ariz.), Rodney DavisRodney Lee DavisBoth sides of the aisle call for local, state, federal cooperation on homelessness Voting equipment companies throw weight behind enhanced disclosures Voting machine vendors to testify on election security MORE (Ill.) and Scott PerryScott Gordon PerryKoch network could target almost 200 races in 2020, official says Overnight Health Care: New drug price hikes set stage for 2020 fight | Conservative group to spend M attacking Pelosi drug plan | Study finds Medicaid expansion improved health in Southern states Conservative group to spend M attacking Pelosi's drug pricing plan MORE (Pa.).

Democrats plan to run on the issue of high drug costs in 2020, touting their House-passed plan, which would require the federal government negotiate lower prices for drugs covered by Medicare.

ADVERTISEMENT

Polls show Medicare price negotiation is extremely popular with voters, putting Republicans, who don't support the plan, in a tight spot. 

Instead, Republicans rolled out an alternative drug pricing plan that would not allow price negotiation but does cap out-of-pocket costs for seniors on Medicare. It would also require drug companies submit justifications to the government for large price hikes. 

"These members of Congress have a better plan: one that will make prescription drugs more affordable for patients and kickstart the innovation of new drugs and cures patients need right now," said American Action Network President Dan Conston. 

Republicans argue the Democrats' bill would lead to fewer drug developments in the U.S.

A report from the Congressional Budget Office (CBO) estimated the bill would lead to eight fewer drugs being introduced to the market over the 2020-2029 period. Under current rules, the Food & Drug Administration approves about 30 new drugs a year. 

But Democrats argue current federal law allows drug companies to price-gouge taxpayers. 

According to the CBO, the negotiation provision would save the government $456 billion over 10 years. That money would be used to pay for dental, vision and hearing benefits for Medicare beneficiaries.